BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 15, 2019
View Archived Issues
Suzhou Yunxuan Yiyao Keji Youxian Gongsi discloses CXCR4 antagonists
Read More
Why there's no Emgality equality
Read More
Combination approach could foil pancreatic tumors
Read More
Discovery of novel DS-6930 derivatives by structure-activity relationship analysis
Read More
Chemerin involved in tumorigenesis and metastasis of OSCC and may be useful as a serum biomarker
Read More
TTC21A biallelic mutations induce asthenoteratospermia
Read More
Novel isocytosine deaminase Vcz converts 5-FIC prodrug into toxic 5-FU for cancer therapy
Read More
OPKO reports additional phase II results for OPK-88003 in patients with diabetes and obesity
Read More
Gilead Sciences and Novo Nordisk to collaborate on clinical trial in NASH
Read More
Growth acceleration seen with maralixibat in progressive familial intrahepatic cholestasis
Read More
Odevixibat has beneficial effects in phase II trials in Alagille syndrome, biliary atresia
Read More
FDA approves Balversa for metastatic bladder cancer
Read More
Potential new regenerative strategy identified for OA
Read More
Dragonfly Therapeutics patents proteins binding NKG2D, CD16 and a tumor-associated antigen
Read More
Ionis Pharmaceuticals synthesizes oligonucleotides targeting Smad7
Read More
New data presented from phase III CREDENCE study
Read More
CDK19 inhibitors discovered by Stanford University, Chan Zuckerberg Biohub
Read More
U.S. Department of Health & Human Services, Lentigen Technology describe CAR T cells targeting CD19
Read More
PCAT1 identified as a potential therapeutic target in HNSCC
Read More
Sunshine Lake Pharma initiates phase I study of HEC-110114 tablets
Read More
Harpoon Therapeutics recruiting patients in phase I/II study of HPN-536
Read More
Sorrento Therapeutics expands clinical development program for resiniferatoxin
Read More
Zymeworks initiates phase II study of ZW-25 in HER2-expressing metastatic gastroesophageal cancers
Read More
First patient dosed in global phase II/III ILLUMINATE study of sepofarsen for LCA10
Read More